All In MedTech

Device Trial Radar · NCT02653755

The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer

Last checked: Nov 21, 2026Latest source record: Jun 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

671

Actual

Start

Dec 15, 2015

Primary completion

May 15, 2030

Study completion May 15, 2030

Sponsor

Lead sponsor
Dana-Farber Cancer InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
NanoString Technologies, Inc.
First posted
Jan 12, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Female only, from 50 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This research study is a way of gaining new knowledge about whether patients can omit radiation treatment after undergoing a lumpectomy, also known as "breast conserving surgery". In this trial, we are attempting to identify which patients may not need radiation.

Conditions

  • Breast Cancer Radiation

Interventions

  • ProsignaDevice

    Transcriptional profile of 50 genes used for risk stratification.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Five-Year Risk of Local Regional Recurrence in the Ipsilateral Breast or Lymph Nodes in Women without Adjuvant RadiotherapyTime frame: 5 years

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Johns Hopkins

    Baltimore, Maryland

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.